Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis ; Vol. 15, 2016
EXCLI journal ; Vol. 15, 2016
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Bogaerts, Eliene
Paridaens, Annelies
Verhelst, Xavier
Carmeliet, Peter
Geerts, Anja
van Vlierberghe, Hans
Devisscher, Lindsey
- Handle
-
2003/35814
- URN
-
urn:nbn:de:101:1-201702173259
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bogaerts, Eliene
- Paridaens, Annelies
- Verhelst, Xavier
- Carmeliet, Peter
- Geerts, Anja
- van Vlierberghe, Hans
- Devisscher, Lindsey
Ähnliche Objekte (12)
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival
Rolle der HIF-Prolyl Hydroxylase Enzyme in der akuten Pankreatitis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival
Rolle der HIF-Prolyl Hydroxylase Enzyme in der akuten Pankreatitis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival